News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AstraZeneca PLC (AZN) to Further Develop Targacept, Inc. (TRGT)'s ADHD Drug; Targacept Eligible to Get Over $100 Million



7/8/2009 7:57:19 AM

Bookmark and Share

Reuters -- Targacept Inc said its licensing partner AstraZeneca agreed to pay $10 million milestone payment to further develop Targacept's experimental treatment for attention deficit/hyperactivity disorder (ADHD).

Read at Reuters


comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES